Nyxoah SA was listed on the Nasdaq exchange, and Cantor Fitzgerald reiterated an overweight rating on the company.
2 reports, 2 independent
Updated 00:00
Still developing
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nyxoah SA was listed on the Nasdaq exchange, and Cantor Fitzgerald reiterated an overweight rating on the company.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Nyxoah SA submitted a PMA supplement to the FDA after listing on Nasdaq.1 source
Nyxoah SA listed on Nasdaq with an overweight rating from Cantor Fitzgerald.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.
- Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
- Cantor Fitzgerald and Royal Bank of Canada updated their ratings and positions regarding Rezolve Ai.